Ginkgo biloba.
Study Design
- Type d'étude
- Review
- Population
- Dementia and cerebrovascular disease patients
- Intervention
- Ginkgo biloba. Ginkgo biloba extract
- Comparateur
- None
- Critère de jugement principal
- Dementia and cerebrovascular disease treatment
- Direction de l'effet
- Positive
- Risque de biais
- Unclear
Abstract
Ginkgo biloba is commonly used in the treatment of early-stage Alzheimer's disease, vascular dementia, peripheral claudication, and tinnitus of vascular origin. Multiple trials investigating the efficacy of ginkgo for treating cerebrovascular disease and dementia have been performed, and systematic reviews suggest the herb can improve the symptoms of dementia. Ginkgo is generally well tolerated, but it can increase the risk of bleeding if used in combination with warfarin, antiplatelet agents, and certain other herbal medications. Clinical issues of safety, dosing, use in the perioperative period, and pharmacology are addressed in this review.
Used In Evidence Reviews
Similar Papers
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
Isorhamnetin: A review of pharmacological effects.
Archives of physical medicine and rehabilitation · 2000
Ginkgo biloba extract: mechanisms and clinical indications.
The Cochrane database of systematic reviews · 2007
Ginkgo biloba for cognitive impairment and dementia.
JAMA · 2009
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.
The Cochrane database of systematic reviews · 2009
Ginkgo biloba for cognitive impairment and dementia.
Clinical pharmacokinetics · 2013